330
- Gaddam K, Pimenta E, Thomas SJ, et al. Spironolactone reduces severity of obstructive sleep
apnoea in patients with resistant hypertension: a preliminary report. J Hum Hypertens.
2010;24:532–7. - Moller DS, Lind P, Strunge B, Pedersen EB. Abnormal vasoactive hormones and 24-hour
blood pressure in obstruc- tive sleep apnea. Am J Hypertens. 2003;16:274–80. - Imadojemu VA, Gleeson K, Quraishi SA, Kunselman AR, Sinoway LI, Leuenberger
UA. Impaired vasodilator responses in obstructive sleep apnea are improved with continuous
positive airway pressure therapy. Am J Respir Crit Care Med. 2002;165:950–3. - Ip MS, Lam B, Chan LY, Zheng L, Tsang KW, Fung PC, et al. Circulating nitric oxide is sup-
pressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pres-
sure. Am J Respir Crit Care Med. 2000;162:2166–71. - Phillips BG, Narkiewicz K, Pesek CA, Haynes WG, Dyken ME, Somers VK. Effects of
obstructive sleep apnea on endothelin-1 and blood pressure. J Hypertens. 1999;17:61–6. - Dempsey JA, Veasey SC, Morgan BJ, O’Donnell CP. Pathophysiology of sleep apnea. Physiol
Rev. 2010;90:47–112. - Witkowski A, Prejbisz A, Florczak E, et al. Effects of renal sympathetic denervation on blood
pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and
sleep apnea. Hypertension. 2011;58:559–65. - O’Rourke MF, Nichols WW. Aortic diameter, aortic stiffness, and wave reflection increase
with age and isolated systolic hypertension. Hypertension. 2005;45:652–8. - Doonan RJ, Scheffler P, Lalli M, Kimoff RJ, Petridou ET, Daskalopoulos ME, Daskalopoulou
SS. Increased arterial stiffness in obstructive sleep apnea: a systematic review. Hypertens Res.
2011;34:23–32. - Kohler M, Pepperell JC, Casadei B, et al. CPAP and measures of cardiovascular risk in males
with OSAS. Eur Respir J. 2008;32:1488–96. - Drager LF, Bortolotto LA, Figueiredo AC, et al. Effects of continuous positive airway pressure
on early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med.
2007;176:706–12. - Jones A, Vennelle M, Connell M, et al. The effect of continuous positive airway pressure
therapy on arterial stiffness and endothelial function in obstructive sleep apnea: a randomized
controlled trial in patients without cardiovascular disease. Sleep Med. 2013;14:1260–5. - Vlachantoni IT, Dikaiakou E, Antonopoulos CN, et al. Effects of continuous positive airway
pressure (CPAP) treatment for obstructive sleep apnea in arterial stiffness: a meta-analysis.
Sleep Med Rev. 2013;17:19–28. - Martinez-Garcia MA, Capote F, Campos-Rodriguez F, Lloberes P, Diaz de Atauri MJ, Somoza
M, et al. Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resis-
tant hypertension: the HIPARCO randomized clinical trial. JAMA. 2013;310:2407–15. - Lozano L, Tovar JL, Sampol G, et al. Continuous positive airway pressure treatment in sleep
apnea patients with resistant hypertension: a randomized, controlled trial. J Hypertens.
2010;28(10):2161–8. - Dernaika TA, Kinasewitz GT, Tawk MM. Effects of nocturnal continuous positive airway pres-
sure therapy in patients with resistant hypertension and obstructive sleep apnea. J Clin Sleep
Med. 2009;5(2):103–7. - Durán-Cantolla J, Aizpuru F, Montserrat JM, Ballester E, Terán-Santos J, Aguirregomoscorta
JI, Gonzalez M, Lloberes P, Masa JF, De La Peña M, Carrizo S, Mayos M, Barbé F. Spanish
sleep and breathing group. Continuous positive airway pressure as treatment for systemic
hypertension in people with obstructive sleep apnoea: randomised controlled trial. BMJ.
2010;341:c5991. - Barbé F, Durán-Cantolla J, Capote F, De LPM, Chiner E, Masa JF, et al. Long-term effect of
continuous positive airway pressure in hypertensive patients with sleep apnea. Am J Respir
Crit Care Med. 2010;181:718–26.
A. Özkök et al.